UC Riverside launches project to test protein therapy for Fragile X syndrome

A new research initiative at the University of California, Riverside has secured funding to explore a protein-based therapy aimed at correcting abnormal brain activity in Fragile X syndrome. This project represents a novel approach to addressing the neurological aspects of the condition.

Originally published by gnews